EquityBulls

Latest News

Brightcom Group and Project DYNAMO Sign MoU to Advance Disaster Preparedness and Civilian Resilience Using Defence-Grade Systems
LGT India Journez recognized Inbound Tour Operator by Ministry of Tourism
NPST Goes Live with NPCI's UPI Services at GFF 2025
AccelerateBS India Ltd signs non-binding MOU to acquire company in USA
Cosmo First achieves globally recognised Information Security Management System Certificate - IS0/IEC 27001:2022

Keywords Selected: Tablets

Stock Report

Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Paroxetine Extended Release Tablets USP, 25 mg and 37.5 mg.
Relonchem Limited receives Marketing Authorization for its products
ZyVet® launches affordable Furosemide tablets to support long-term heart care trusted diuretic for dogs and cats now available in a generic form
NATCO launches Bosentan Tablets for Oral Suspension in the United States with 180-day exclusivity
Lupin launches Bosentan Tablets for Oral Suspension in the United States with 180-Day Exclusivity
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg
Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
Shilpa Medicare announces the approval of Nor Ursodeoxycholic Acid Tablets 500 mg for the treatment of Non‐Alcoholic Fatty Liver Disease in India
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 & 1 mg
Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
J.B. Chemicals & Pharmaceuticals Ltd receives USFDA approval for ANDA Amitriptyline Hydrochloride Tablets
Lupin launches Prucalopride tablets in the United States
Lupin receives approval from U.S. FDA for Prucalopride Tablets
J B Chemicals and Pharmaceuticals Ltd receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
Lupin receives tentative approval from U.S. FDA for Oxcarbazepine ER Tablets
Indoco Remedies Ltd announces the first day launch of Ticagrelor filmcoated tablets through its subsidiary in the United Kingdom
Zydus receives tentative approval from USFDA for Rifaximin Tablets, 550 mg
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Amlodipine and Atorvastatin Tablets USP
Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg
Lupin receives approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg
Alembic Pharmaceuticals receives USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg